Vaxcell Bio Therapeutics Co Stock Profit Margin
| 323990 Stock | KRW 9,380 220.00 2.29% |
Vaxcell Bio Therapeutics Co fundamentals help investors to digest information that contributes to Vaxcell-Bio Therapeutics' financial success or failures. It also enables traders to predict the movement of Vaxcell-Bio Stock. The fundamental analysis module provides a way to measure Vaxcell-Bio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaxcell-Bio Therapeutics stock.
Vaxcell-Bio |
Vaxcell Bio Therapeutics Co Company Profit Margin Analysis
Vaxcell-Bio Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Vaxcell Bio Therapeutics Co has a Profit Margin of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Profit Margin (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Vaxcell-Bio Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaxcell-Bio Therapeutics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vaxcell-Bio Therapeutics could also be used in its relative valuation, which is a method of valuing Vaxcell-Bio Therapeutics by comparing valuation metrics of similar companies.Vaxcell Bio is currently under evaluation in profit margin category among its peers.
Vaxcell-Bio Fundamentals
| Return On Equity | -21.18 | |||
| Current Valuation | 1.06 T | |||
| Shares Owned By Insiders | 13.55 % | |||
| Shares Owned By Institutions | 3.92 % | |||
| Gross Profit | (5.39 M) | |||
| EBITDA | (4.06 B) | |||
| Net Income | (4.76 B) | |||
| Cash And Equivalents | 27.31 B | |||
| Total Debt | 37.39 M | |||
| Cash Flow From Operations | (4.66 B) | |||
| Market Capitalization | 554.12 B | |||
| Total Asset | 31.28 B | |||
| Net Asset | 31.28 B |
About Vaxcell-Bio Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaxcell Bio Therapeutics Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaxcell-Bio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaxcell Bio Therapeutics Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Vaxcell-Bio Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxcell-Bio Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcell-Bio Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Vaxcell-Bio Stock
Moving against Vaxcell-Bio Stock
The ability to find closely correlated positions to Vaxcell-Bio Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxcell-Bio Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxcell-Bio Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxcell Bio Therapeutics Co to buy it.
The correlation of Vaxcell-Bio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxcell-Bio Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxcell-Bio Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxcell-Bio Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Vaxcell-Bio Stock
Vaxcell-Bio Therapeutics financial ratios help investors to determine whether Vaxcell-Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vaxcell-Bio with respect to the benefits of owning Vaxcell-Bio Therapeutics security.